<!DOCTYPE html>
<html>
<head>
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>      
	<style>
	.show {display: block;}
  .tablist-left {
    width: 25%;
    display: inline-block;
  }
  .tablist-content {
    width: 60%;
    display: inline-block;
    vertical-align: top;
    margin-left: 5%;
    }
    body {
  font-family: Arial, Helvetica, sans-serif;
  font-size: 20px;
}
.footer-button-left,
.footer-button-right {
    position: absolute;
    margin: 0;
    top: auto;
    bottom: 0.24em;
}
.footer-button-left {
    left: 0.4em;
}
.footer-button-right {
    right: 0.4em;
}
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Lucida Grande";}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:18.0pt;
	margin-left:0cm;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:9.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p
	{margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:9.0pt;
	font-family:"Lucida Grande","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Lucida Grande","sans-serif";}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Arial","sans-serif";}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-style:italic;}
span.UnresolvedMention
	{mso-style-name:"Unresolved Mention";
	color:#605E5C;
	background:#E1DFDD;}
p.headinganchor, li.headinganchor, div.headinganchor
	{mso-style-name:headinganchor;
	margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.h1
	{mso-style-name:h1;}
span.headingendmark
	{mso-style-name:headingendmark;}
span.h2
	{mso-style-name:h2;}
span.nowrap
	{mso-style-name:nowrap;}
p.breakall, li.breakall, div.breakall
	{mso-style-name:breakall;
	margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Tahoma","sans-serif";}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
   .tableCont {
    overflow: auto;
    -webkit-overflow-scrolling: touch;
}
  </style>
  	  	<script>
		$(function(){
			$( "[data-role='header'], [data-role='footer']" ).toolbar();
			$('input[data-type="search"]').val("");			
		});
		// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}
	</script>

</head>
<body lang=EN-GB link=blue vlink=purple>
	<div data-role="header" data-tap-toggle="false" data-id="persistent-header" data-position="fixed" data-theme="a">
		<h2 style="font-size:0.75em;"><br><br><br>MRCG<br>Clinical Guidelines</h2>
		<a data-rel="back" class="ui-btn ui-corner-all ui-btn-inline ui-mini header-button-left ui-btn-icon-left ui-icon-carat-l">Back</a>
		<a href="#leftpanel1" class="ui-btn ui-shadow ui-corner-all ui-btn-inline ui-mini header-button-left ui-icon-info ui-btn-icon-notext">About this app</a>
		<a href="#popupNested"  data-rel="popup" class="ui-btn ui-corner-all ui-shadow ui-btn-inline ui-icon-bars ui-btn-icon-right ui-btn-b header-button-right" data-transition="pop">Choose a guideline...</a>
		<div data-role="popup" id="popupNested" data-theme="a"><ul data-role="listview" data-filter="true"data-filter-placeholder="Type to search names..." data-inset="true">
			<li><a href="Acute_kidney_injury_MeG-CLS-071.html">Acute kidney injury</a></li>
			<li><a href="Acute_rheumatic_fever__MeG-CLS-048.html">Acute rheumatic fever </a></li>
			<li><a href="Animal_bites_MeG-CLS-049.html">Animal bites</a></li>
			<li><a href="Asthma_MeG-CLS-001.html">Asthma</a></li>
			<li><a href="Bone_and_joint_infections_guidelines_MeG-CLS-050.html">Bone and joint infections guidelines</a></li>
			<li><a href="Cellulitis_MeG-CLS-051.html">Cellulitis</a></li>
			<li><a href="Chest_pain_and_Acute_Coronary_Syndrome_MeG-CLS-052.html">Chest pain and Acute Coronary Syndrome</a></li>
			<li><a href="Chronic_kidney_disease_MeG-CLS-053.html">Chronic kidney disease</a></li>
			<li><a href="Congenital_heart_disease_MeG-CLS-039.html">Congenital heart disease</a></li>
			<li><a href="Constipation_MeG-CLS-003.html">Constipation</a></li>
			<li><a href="COPD_MeG-CLS-032.html">Chronic Obstructive Pulmonary Disease</a></li>
			<li><a href="Croup_MeG-CLS-059.html">Croup</a></li>
			<li><a href="Deep_venous_thombosis_and_pulmonary_embolism_MeG-CLS-055.html">Deep venous thombosis and pulmonary embolism</a></li>
			<li><a href="Depression_MeG-CLS-075.html">Depression</a></li>
			<li><a href="Developmental_delay_MeG-CLS-054.html">Developmental delay</a></li>
			<li><a href="Diabetes_Mellitus_MeG-CLS-004.html">Diabetes Mellitus</a></li>
			<li><a href="DKA_MeG-CLS-021.html">Diabetic ketoacidosis</a></li>
			<li><a href="Dyspepsia_MeG-CLS-034.html">Dyspepsia</a></li>
			<li><a href="Ear_pain_MeG-CLS-070.html">Ear pain</a></li>
			<li><a href="Epiglottitis_MeG-CLS-063.html">Epiglottitis</a></li>
			<li><a href="Epilepsy_MeG-CLS-056.html">Epilepsy</a></li>
			<li><a href="Fungal_Skin_Infections_MeG-CLS-057.html">Fungal Skin Infections</a></li>
			<li><a href="Gastroenteritis_MeG-CLS-033.html">Gastroenteritis</a></li>
			<li><a href="General_Body_Pain_MeG-CLS-007.html">General Body Pain</a></li>
			<li><a href="Headache_MeG-CLS-045.html">Headache</a></li>
			<li><a href="Heart_failure_adults_MeG-CLS-040.html">Heart failure adults</a></li>
			<li><a href="HHS_MeG-CLS-046.html">Hyperosmolar Hyperglycaemic State</a></li>
			<li><a href="HIV_MeG-CLS-035.html">HIV</a></li>
			<li><a href="Hypertension_MeG-CLS-010.html">Hypertension</a></li>
			<li><a href="Hyperthyroidism_and_goitre_MeG-CLS-027.html">Hyperthyroidism and goitre</a></li>
			<li><a href="Hypocalcaemia_and_hypercalcaemia_MeG-CLS-074.html">Hypocalcaemia and hypercalcaemia</a></li>
			<li><a href="Hypokalaemia_hyperkalaemia_hypermagnesaemia_MeG-CLS-073.html">Hypokalaemia, hyperkalaemia, hypermagnesaemia</a></li>
			<li><a href="Hyponatraemia_and_hypernatraemia_MeG-CLS-072.html">Hyponatraemia and hypernatraemia</a></li>
			<li><a href="Hypothyroidism_MeG-CLS-036.html">Hypothyroidism</a></li>
			<li><a href="Infective_Endocarditis_MeG-CLS-058.html">Infective Endocarditis</a></li>
			<li><a href="Inflammatory_arthritis_and_connective_tissue_disease_MeG-CLS-041.html">Inflammatory arthritis and connective tissue disease</a></li>
			<li><a href="Intestinal_helminths_MeG-CLS-009.html">Intestinal helminths</a></li>
			<li><a href="Liver_disease_MeG-CLS-031.html">Liver disease</a></li>
			<li><a href="Lower_back_pain_MeG-CLS-022.html">Lower back pain</a></li>
			<li><a href="LRI_MeG-CLS-011.html">Lower Respiratory Infections</a></li>
			<li><a href="Malaria_MeG-CLS-012.html">Malaria</a></li>
			<li><a href="Malnutrition_MeG-CLS-037.html">Malnutrition</a></li>
			<li><a href="Meningitis_MeG-CLS-028.html">Meningitis</a></li>
			<li><a href="Neonatal_jaundice_MeG-CLS-060.html">Neonatal jaundice</a></li>
			<li><a href="Nephrotic_Syndrome_MeG-CLS-061.html">Nephrotic Syndrome</a></li>
			<li><a href="Osteoarthritis_MeG-CLS-042.html">Osteoarthritis</a></li>
			<li><a href="Otitis_media_MeG-CLS-023.html">Otitis media</a></li>
			<li><a href="Palliative_Care_MeG-CLS-064.html">Palliative Care</a></li>
			<li><a href="Rectal_prolapse_MeG-CLS-015.html">Rectal prolapse</a></li>
			<li><a href="Rheumatic_heart_disease_MeG-CLS-065.html">Rheumatic heart disease</a></li>
			<li><a href="Scabies_MeG-CLS-066.html">Scabies</a></li>
			<li><a href="Sepsis_in_adults_MeG-CLS-043.html">Sepsis in adults</a></li>
			<li><a href="Sinusitis_MeG-CLS-062.html">Sinusitis</a></li>
			<li><a href="Stevens-Johnsons_syndrome_MeG-CLS-067.html">Stevens-Johnsons syndrome</a></li>
			<li><a href="STI_MeG-CLS-038.html">Sexually Transmitted Infections</a></li>
			<li><a href="Stroke_MeG-CLS-020.html">Stroke</a></li>
			<li><a href="TB_MeG-CLS-044.html">TB</a></li>
			<li><a href="Tonsillitis_and_pharyngitis_MeG-CLS-024.html">Tonsillitis and pharyngitis</a></li>
			<li><a href="Trauma_MeG-CLS-068.html">Trauma</a></li>
			<li><a href="Upper_respiratory_tract_infections_MeG-CLS-018.html">Upper respiratory tract infections</a></li>
			<li><a href="UTI_MeG-CLS-019.html">Urinary tract infections</a></li>
</ul>
	  </div>
	  </div>
	 
    </div><!-- /header -->
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Chest Pain And Acute Coronary Syndromes </span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>Cardiovascular disease represents the
leading cause of morbidity and mortality worldwide. Chest pain secondary to
myocardial ischaemia in the forms of stable angina and acute coronary syndromes
(ACS), often referred to as a ‘heart attack’, represent perhaps the most
well-known presentations of cardiovascular disease (table 1). The prevalence of
cardiovascular disease and resultant ACS continues to rise in low-income
settings. Despite this cardiac chest pain and ACS are understudied and have
poor outcomes in Sub-Saharan Africa<i>.</i> </span></p>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline discusses how to identify
cardiac chest pain, how to classify severity and the management of both chronic
cardiac chest pain and acute coronary syndromes. </span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>None</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Background and definitions</span></h2>
<p class=MsoNormal><span lang=EN-US>Chest pain is an extremely common
presenting complaint, present in approximately 20% of medical admissions to
hospital<i>.</i> It is a distressing symptom and can be concerning for both
patients and health care professionals – often due to worries about potentially
life threatening aetiologies such as ACS. The majority of chest pain is not
cardiac in origin though (table 2) and can be managed as an outpatient. The
wide variety of possible differential diagnoses (table 3) can make the task of
identifying the underlying cause of chest pain and treating it appropriately extremely
daunting. The key to the management of these patients is a thorough assessment
to help identifying the underlying cause and early recognition of signs of
possible life threatening aetiologies. </span></p>
<p class=MsoNormal><span lang=EN-US>Table 1: Important terms in chest pain
related to cardiovascular disease</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Term </span></b></p>
  </td>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Explanation</span></b></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Ischaemic Heart Disease </span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Also
  referred to as coronary heart disease, is present when a patient has one or
  more symptoms, signs, or complications from an inadequate supply of blood to
  the myocardium. This is most commonly due to obstruction of the epicardial
  coronary arteries due to atherosclerosis.</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Angina</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Occurs
  when myocardial oxygen demand exceeds oxygen supply; the clinical
  manifestation is often chest discomfort.</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Stable Angina</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Refers
  to chest discomfort that occurs predictably and reproducibly at a certain
  level of exertion and is relieved with rest or&nbsp;</span><span lang=EN-US>nitrates.</span><span
  lang=EN-US style='color:black;background:white'> Most patients with ischaemic
  heart disease will experience angina as part of the clinical manifestations
  of the disease.</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Acute Coronary Syndrome (ACS)</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Applied
  to patients in whom there is a suspicion or confirmation of acute myocardial ischaemia
  or infarction. Non-ST elevation myocardial infarction (NSTEMI), unstable
  angina (UA), and ST-elevation myocardial infarction (STEMI) are the three
  types of ACS.</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>STEMI</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Myocardial
  ischaemia with raised markers of myocardial injury (troponin, CK-MB) and
  characteristic ECG changes (predominantly ST elevation).</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>NSTEMI</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Myocardial
  ischemia with raised markers of myocardial injury without the characteristic
  ECG changes of STEMI. </span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Unstable Angina </span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Myocardial
  ischemia without raised markers of myocardial injury. </span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Table 2: Aetiology of chest pain</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><i><span lang=EN-US>&nbsp;</span></i></b></p>
  </td>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Percentage of Patients Presenting </span></b></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Musculoskeletal </span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>30 – 50%</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Gastro-intestinal</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>10 – 20%</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Stable Angina</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>10%</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Respiratory Conditions</span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>5%</span></p>
  </td>
 </tr>
 <tr>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Acute Coronary Syndromes </span></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>2 – 4%</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Table 3: Differential diagnoses of chest
pain</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US> Cardiac </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Ischaemic </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Stable Angina </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Acute Coronary Syndrome </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Non-Ischaemic </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Aortic Dissection </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Pulmonary </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Pulmonary Embolism </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Malignancy </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Pulmonary Hypertension </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Gastro-intestinal </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Oesophagitis </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Musculoskeletal </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Isolated musculoskeletal pain – i.e. costochrondritis </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Trauma </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Psychiatric </span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Panic Attacks/Disorder </span></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b><span lang=EN-US>Other</span></b></p> </tr>
  <tr  valign=top style='border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US>Referred Pain </span></p> </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and Signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Given the variety of possible diagnoses
underlying chest pain, thorough history taking is of the utmost importance. </span></p>
<p class=MsoNormal><span lang=EN-US>Early assessment should focus on symptoms
and signs of chest pain with possible life-threatening aetiologies. Any
patients in whom there are concerns for life-threatening causes of chest pain
should be referred urgently to the ward for further assessment:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Unstable vital signs.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Abrupt onset of chest pain and/or clinical
concern for life-threatening aetiology (e.g. pulmonary embolism, aortic
dissection, esophageal rupture, tension pneumothorax). </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Concern for acute coronary syndrome (ACS) based
on symptoms (anginal symptoms at rest, prolonged, or progressing episodes).</span></p>
<p class=MsoNormal><span lang=EN-US>Assess patients presenting with chest pain
for typical signs of angina (table 4). Classic symptoms of stable angina
include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A pressure, heaviness, tightness, or
constriction in the center or left of the chest that is precipitated by
exertion and relieved by rest. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Provocation with emotional stress or cold</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Radiation (to the neck, jaw, and shoulder)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Dyspnoea</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nausea and vomiting</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Sweating</span></p>
<p class=MsoNormal><span lang=EN-US>Severity of pain is not a useful
differentiating factor and it is important to note no symptom alone or in
combination identifies a group of patients in whom the diagnosis can be
entirely excluded. </span></p>
<p class=MsoNormal><span lang=EN-US>The clinical presentation of myocardial
ischemia varies by population. Women, diabetics, and older adult patients are
more likely to present without chest pain but have symptoms of dyspnoea,
weakness, nausea and vomiting, palpitations, or syncope<i>. </i>Compared with
older patients, younger patients are less likely to have stable angina and have
a higher incidence of ACS<i>.</i>  </span></p>
<p class=MsoNormal><span lang=EN-US>Patients who present with ACS have:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Anginal symptoms at rest (usually greater than
20 minutes)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>New-onset angina that is not stable and
predictable</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Progressive symptoms (angina that is more
frequent, longer in duration, or occurs with less exertion than previously). </span></p>
<p class=MsoNormal><span lang=EN-US>These patients should be admitted urgently.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Table 4: Assessment of chest pain</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 
 style=‘ ;border-collapse:collapse;border:none'>
 <tr style='height:14.45pt'>
  <td colspan=2 valign=top style='border:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:14.45pt'>
  <p class=MsoNormal><b><span lang=EN-US>Stratification of Chest Pain </span></b></p>
  </td>
 </tr>
 <tr style='height:13.1pt'>
  <td valign=top style='border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:13.1pt'>
  <p class=MsoNormal><b><span lang=EN-US>Typical Angina</span></b></p>
  </td>
  <td valign=top style='border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:13.1pt'>
  <p class=MsoNormal><span lang=EN-US>Presence of three of the three features
  of anginal chest pain</span></p>
  </td>
 </tr>
 <tr style='height:13.1pt'>
  <td valign=top style='border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:13.1pt'>
  <p class=MsoNormal><b><span lang=EN-US>Atypical Angina</span></b></p>
  </td>
  <td valign=top style='border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:13.1pt'>
  <p class=MsoNormal><span lang=EN-US>Presence of two of the features anginal
  chest pain</span></p>
  </td>
 </tr>
 <tr style='height:20.8pt'>
  <td valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:solid windowtext 1.0pt;border-right:none;padding:0cm 5.4pt 0cm 5.4pt;
  height:20.8pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-Anginal Chest Pain </span></b></p>
  </td>
  <td valign=top style='border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;
  border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:20.8pt'>
  <p class=MsoNormal><span lang=EN-US>Presence of one or none of the features
  of anginal chest pain</span></p>
  </td>
 </tr>
 <tr style='height:16.05pt'>
  <td colspan=2 valign=top style='border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:16.05pt'>
  <p class=MsoNormal><b><span lang=EN-US>Features of Anginal Chest Pain</span></b></p>
  </td>
 </tr>
 <tr style='height:19.15pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:19.15pt'>
  <p class=MsoNormal><span lang=EN-US>Constricting discomfort in the front of
  the chest, or in the neck, shoulders, jaw or arm</span></p>
  </td>
 </tr>
 <tr style='height:20.5pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:20.5pt'>
  <p class=MsoNormal><span lang=EN-US>Precipitated by physical exertion</span></p>
  </td>
 </tr>
 <tr style='height:11.45pt'>
  <td colspan=2 valign=top style='border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:11.45pt'>
  <p class=MsoNormal><span lang=EN-US>Relieved by rest or GTN within about 5
  minutes</span></p>
  </td>
 </tr>
 <tr style='height:13.1pt'>
  <td colspan=2 valign=top style='border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:13.1pt'>
  <p class=MsoNormal><b><span lang=EN-US>Features Suggestive of Non-Anginal Chest
  Pain</span></b></p>
  </td>
 </tr>
 <tr style='height:13.1pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:13.1pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Pleuritic
  pain, sharp or knife-like pain related to respiratory movements or cough</span></p>
  </td>
 </tr>
 <tr style='height:13.85pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:13.85pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Primary
  or sole location in the mid or lower abdominal region</span></p>
  </td>
 </tr>
 <tr style='height:14.55pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:14.55pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Any
  discomfort localized with one finger</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:3.5pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Any
  discomfort reproduced by movement or palpation</span></p>
  </td>
 </tr>
 <tr style='height:17.8pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:17.8pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Constant
  pain lasting for days</span></p>
  </td>
 </tr>
 <tr style='height:13.75pt'>
  <td colspan=2 valign=top style='border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:13.75pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Fleeting
  pains lasting for a few seconds or less</span></p>
  </td>
 </tr>
 <tr style='height:13.7pt'>
  <td colspan=2 valign=top style='border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:13.7pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Pain
  radiating into the lower extremities or above the mandible</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<h2><span lang=EN-US>Examination </span></h2>
<p class=MsoNormal><span lang=EN-US>A focused examination of the patient with
chest pain should include a cardiovascular, respiratory and abdominal
examination, thereby broadly assessing the most likely underlying aetiologies.
In many cases there may be few findings on examination and further
investigation will be warranted. </span></p>
<h2><span lang=EN-US>Investigations</span></h2>
<p class=MsoNormal><span lang=EN-US>Patients with typical signs of stable
angina and no other concerning features should be commenced on anginal therapy,
but investigations (table 5) may be warranted if there are concerns about other
possible causes. </span></p>
<p class=MsoNormal><span lang=EN-US>ECGs may be limited in the outpatient
setting due to the cost to patients, but should be used if they will help make a
diagnosis or change management plans. Concerns over ACS should prompt referral
to the ward where an ECG can be performed as an in-patient. </span></p>
<p class=MsoNormal><span lang=EN-US>Patients with atypical cardiac chest pain
should be investigated further. If there is no other clear cause, and especially
in patients with a high number of cardiac risk factors (age, smoking,
hypertension, diabetes, dyslipidaemia, family history of coronary heart disease,
etc) they should be commenced on anginal treatment and monitored closely for
response to therapy.   </span></p>
<p class=MsoNormal><span lang=EN-US>Patients with non-anginal chest pain should
be investigated further unless a clear diagnosis of a non-life threatening
aetiology can be made clinically. For example clear musculoskeletal chest pain
or a clear (low risk) pneumonia may not require any further investigation. </span></p>
<p class=MsoNormal><span lang=EN-US>Patients admitted to the ward with chest
pain should have urgent bloods (full blood count, urea and electrolytes, CK-MB
if concerns over cardiac pain), an ECG and a chest x-ray. Other investigations
may also be required depending on the clinical situation.  </span></p>
<p class=MsoNormal><span lang=EN-US>Table 5: Investigation of patients with
chest pain</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 
 style=‘ ;border-collapse:collapse;border:none'>
 <tr style='height:3.5pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:3.5pt'>
  <p class=MsoNormal><b><span lang=EN-US>Investigation</span></b></p>
  </td>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.5pt'>
  <p class=MsoNormal><b><span lang=EN-US>Role and Interpretation </span></b></p>
  </td>
 </tr>
 <tr style='height:17.95pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:17.95pt'>
  <p class=MsoNormal><b><span lang=EN-US>ECG</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:17.95pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>A
  standard 12-lead electrocardiogram (ECG) should be obtained for all patients
  presenting with chest pain that may be from an ACS. </span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>ECG
  remains the best immediately available test for detecting ACS but its
  sensitivity for acute myocardial infarction (AMI) is low. The initial ECG is
  often&nbsp;<strong><span style='font-family:"Arial","sans-serif"'>NOT</span></strong>&nbsp;diagnostic
  in patients with ACS and can be repeated as frequently as every 10 minutes if
  the initial ECG is not diagnostic but the patient remains symptomatic and
  there remains high clinical suspicion for AMI. Prior ECGs are important for
  determining whether abnormalities are new. The presence of a left bundle
  branch block makes it difficult to determine the presence of ischemic ECG
  changes.</span></p>
  <p class=MsoNormal><span lang=EN-US>Findings consistent with ST elevation
  myocardial infarction (STEMI): New ST elevation at the J point in two
  anatomically contiguous leads using the following diagnostic thresholds:
  &#8805;0.1 mV (1 mm) in all leads other than V2-V3, where the following
  diagnostic thresholds apply: &#8805;0.2 mV (2 mm) in men &#8805; 40 years;
  &#8805;0.25 mV (2.5 mm) in men &lt;40 years, or &#8805;0.15 mV (1.5 mm) in
  women. </span></p>
  <p class=MsoNormal><span lang=EN-US>Findings consistent with Non ST elevation
  myocardial infarction or unstable angina: New horizontal or down-sloping ST
  depression &#8805;0.05 mV (0.5 mm) in two anatomically contiguous leads
  and/or T inversion &#8805;0.1 mV (1 mm) in two anatomically contiguous leads
  with prominent R wave or R/S ratio &gt;1.</span></p>
  </td>
 </tr>
 <tr style='height:17.95pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:17.95pt'>
  <p class=MsoNormal><b><span lang=EN-US>Chest X-Ray (CXR)</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:17.95pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>A
  CXR should be performed in all patients unless a probable underlying cause
  that does not require imaging has already been identified in a stable
  patient. </span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>A
  nondiagnostic CXR is typical in patients with&nbsp;<strong><span
  style='font-family:"Arial","sans-serif";font-weight:normal'>ACS and stable
  angina.o</span></strong></span><strong><span lang=EN-US style='font-family:
  "Arial","sans-serif";font-weight:normal'>r pulmonary embolus</span></strong><strong><span
  lang=EN-US style='font-family:"Arial","sans-serif";color:black;background:
  white;font-weight:normal'> (PE</span></strong><strong><span lang=EN-US
  style='font-family:"Arial","sans-serif";font-weight:normal'>)</span></strong></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Approximately
  90 percent of patients with&nbsp;<strong><span style='font-family:"Arial","sans-serif";
  font-weight:normal'>acute aortic dissection</span></strong>&nbsp;will have
  some CXR abnormality</span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Pneumonia
  and pneumothorax are often diagnosed by CXR. </span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Acute
  heart failure is suggested by pulmonary vascular congestion and cardiomegaly.
  In patients with severe vomiting or recent instrumentation of the oesophagus,
  mediastinal emphysema and pleural effusion suggest&nbsp;o<strong><span
  style='font-family:"Arial","sans-serif";font-weight:normal'>esophageal
  rupture</span></strong>.</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 
 style=‘ ;border-collapse:collapse;border:none'>
 <tr style='height:17.95pt'>
  <td  colspan=2 valign=top style=‘ ;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:17.95pt'>
  <p class=MsoNormal><b><span lang=EN-US>Blood Tests</span></b></p>
  </td>
 </tr>
 <tr style='height:83.2pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:83.2pt'>
  <p class=MsoNormal><b><span lang=EN-US>CK-MB</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:83.2pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Creatine
  kinase MB (CK-MB) isoform levels rise to twice normal at six hours and peak
  within approximately 24 hours post myocardial injury. Note should be made of
  the time pain started and when the test was taken. An initial test should be
  performed on admission for anyone who may have ACS and a repeat after 6-9
  hours to assess for ongoing changes,</span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Although
  it is no longer recommended for most patients being evaluated for ACS due to
  the higher accuracy of troponin assays, it is the available option here at
  present. </span></p>
  </td>
 </tr>
 <tr style='height:25.95pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:25.95pt'>
  <p class=MsoNormal><b><span lang=EN-US>Full Blood Count</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:25.95pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>The
  white blood cell count may be elevated in any of the inflammatory or
  infectious etiologies of chest pain. Anaemia in a patient with exertional
  chest pain is suggestive of myocardial ischemia, but also consistent with
  aortic rupture.</span></p>
  </td>
 </tr>
 <tr style='height:18.25pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:18.25pt'>
  <p class=MsoNormal><b><span lang=EN-US>Urea and Electrolytes</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:18.25pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Raised
  urea and other markers indicating dehydration and acute kidney injury may
  accompany many forms of chest pain. Abnormalities in these tests often
  indicates a poorer prognosis.</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td  colspan=2 valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.5pt'>
  <p class=MsoNormal><b><span lang=EN-US>Further Possible Investigations</span></b></p>
  </td>
 </tr>
 <tr style='height:56.15pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:56.15pt'>
  <p class=MsoNormal><b><span lang=EN-US>Transthoracic Echocardiogram </span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:56.15pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>May
  show regional wall abnormalities in patients with acute coronary syndromes or
  prior myocardial injury. </span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>May
  show signs of right heart strain and features of raised pulmonary pressure in
  pulmonary embolism.</span></p>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Will
  demonstrate significant valvular disease and left ventricular dysfunction if
  present. </span></p>
  </td>
 </tr>
 <tr style='height:21.9pt'>
  <td  valign=top style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:21.9pt'>
  <p class=MsoNormal><b><span lang=EN-US>USS Doppler (lower legs)</span></b></p>
  </td>
  <td  valign=top style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:21.9pt'>
  <p class=MsoNormal><span lang=EN-US style='color:black;background:white'>Can
  be used as a surrogate investigation if there are concerns over a 
  (non-massive) pulmonary embolism. </span></p>
  </td>
 </tr>
</table>
</div>
<h2><span lang=EN-US>Management </span></h2>
<p class=MsoNormal><span lang=EN-US>Non-cardiac causes of chest pain such as
pneumonia and musculoskeletal pain should be managed as described in their
separate guidance. The following will focus on the management of stable angina
and ACS.</span></p>
<h3><span lang=EN-US>Management of stable angina</span></h3>
<p class=MsoNormal><i><span lang=EN-US>Anti-anginal therapy</span></i><span
lang=EN-US>:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Beta-blockers</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>First line therapy to
reduce anginal episodes and improve exercise tolerance. The only antianginal
drugs proven to prevent reinfarction and to improve survival in patients who
have sustained a myocardial infarction </span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Bisoprolol: Start at 1.25
mg OD immediately and uptitrate to 10 mg daily, as tolerated and according to
symptomatic response (can be given in divided doses). </span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>Dose can be increased in
1.25-2.5mg steps, aiming to double every 2 weeks until target dose is reached.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Calcium</span></b><span lang=EN-US> <b>Channel Blockers</b></span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Used in combination with
beta blockers when initial treatment with beta blockers is not successful or as
a substitute for a beta blocker when beta blockers are contraindicated or cause
side effects.</span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Amlodipine: Start at 5 mg
OD and uptitrate to 10 mg OD as tolerated and according to symptomatic
response.</span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>This should be initiated
following maximal uptitration of a beta-blocker.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Nitrates</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>First-line therapy for the
treatment of&nbsp;acute&nbsp;anginal symptoms. Usually in the form of a
sublingual preparation&gt; Patients should be instructed to use them at the
onset of angina. They may also be recommended for the prophylaxis of anginal
episodes.</span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>GTN sublingual tablets:
300-500 micrograms as required. Up to three times with 5 minute intervals for
relief of acute anginal pain.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Anti-platelet therapy:</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Aspirin </span></b></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:10.8pt;margin-right:0cm;
margin-bottom:10.8pt;margin-left:36.0pt;line-height:15.1pt;background:white'><span
style='color:black'>In the absence of a contraindication, all patients with
definite angina should be treated with aspirin. Patients who have a
gastrointestinal bleed on low-dose aspirin should, after the episode is
controlled, be treated with aspirin plus a proton pump inhibitor.&nbsp;</span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Aspirin: 75 mg OD.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Clopidogrel</span></b></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:10.8pt;margin-right:0cm;
margin-bottom:10.8pt;margin-left:36.0pt;line-height:15.1pt;background:white'><span
style='color:black'>Can be given as an <b>alternative</b> to aspirin in stable
angina if the patient has aspirin intolerance. Available from CSD pharmacy only
for staff.</span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>Clopidogrel: 75 mg OD.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Preventative therapy:</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Statins</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Reduce cholesterol and
prevent future cardiovascular disease.</span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Atorvastatin: 40-80 mg
Nocte.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Risk factor reduction</span></b></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>A central component of the </span><span
style='color:black'>management of patients with stable angina. This includes
treatment of hypertension, cessation of smoking, weight reduction, glycaemic
control in diabetics and participation in regular physical activity.</span></p>
<h3><span lang=EN-US>Management of NSTEMI / unstable angina:</span></h3>
<p class=MsoNormal><i><span lang=EN-US>Anti-thrombotic therapy:</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Anti-platelet agents</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Aspirin 300 mg AND
clopidogrel 300 mg given as a stat dose as soon as possible.</span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Ideally aspirin 75 mg and
clopidogrel 75 mg OD to continue for 1 year following this.</span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>Aspirin can be used as a
monotherapy in the absence of clopidogrel, though with lower efficacy.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Anticoagulation</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Enoxaparin should be
started immediately and given for 5 days post ACS (1 mg/kg 12 hourly):
Available for members of staff only – patients should be encouraged to buy this
if they can. </span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>Unfractionated heparin can
be used as an alternative to enoxaparin, but has worse clinical outcomes. We
cannot measure APTT out-of-hours, so are not able to use it iv. If there is no
alternative then sc heparin can be given at a dose of 15,000 units BD, as this
is likely to be better than nothing. </span></p>
<p class=MsoNormal><i><span lang=EN-US>Anti-ischaemic and analgesic therapy:</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Oxygen</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US style='color:black;
background:white'>Administer supplemental oxygen to ACS patients with an
arterial saturation less than 90 percent.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>GTN</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Sublingual GTN (300-500microgams):
Consider intravenous GTN in patients with persistent pain after three
sublingual GTN tablets, hypertension, or heart failure.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Morphine</span></b></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>IV morphine should be
avoided if possible and reserved for patients with an unacceptable level of
pain. If needed give intravenous morphine 2 to 4 mg, with increments of 2 to 8
mg repeated at 5- to 15-minute intervals.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Further inpatient management:</span></i></p>
<p class=MsoNormal><span lang=EN-US>Initiation of anti-anginal medications as
per stable angina. </span></p>
<p class=MsoNormal><span lang=EN-US>A beta-blocker should be started in the
first 24 hours if able. </span></p>
<p class=MsoNormal><span lang=EN-US>When stable an ACE inhibitor may be started
if there is evidence of heart failure, hypertension or chronic kidney disease.</span></p>
<h3><span lang=EN-US>Management of STEMI</span></h3>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><b><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Fibrinolytic therapy</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Streptokinase 1500000
units (15 million units) to be initiated as soon as possible and within 12
hours of symptom onset as an infusion over 60 minutes. Outside of 12 hours,
there is limited evidence for benefit. </span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Assess for bleeding risk
prior to make a risk-benefit decision.</span><span lang=EN-US style='color:
black;background:white'> Streptokinase is antigenic, and can cause immunologic
sensitization and allergic reactions, particularly with repeat administration</span><span
lang=EN-US> </span></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Consultant input is
advised.  </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Anti-thrombotic therapy</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>Aspirin 300 mg and
clopidogrel 300 mg should be given as a stat dose as soon as possible and
continued as 75 mg OD following this for 1 year. Aspirin monotherapy can be
continued after this.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Anticoagulant Therapy</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>As per NSTEMI protocol. Anticoagulate
with enoxaparin or unfractionated heparin for 5 days.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><b><span
lang=EN-US>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></b><b><span
lang=EN-US>Further inpatient management</span></b></p>
<p class=MsoListParagraphCxSpMiddle><span lang=EN-US>As per NSTEMI protocol. Early
initiation of a beta-blocker (1<sup>st</sup> 24 hours) is recommended.</span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US>&nbsp;</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt'>Bösner, S., Becker,
A., Haasenritter, J., Hani, M. A., Keller, H., Sönnichsen, A. C., Donner-Banzhoff,
N. (2009). Chest pain in primary care: Epidemiology and pre-work-up
probabilities. European Journal of General Practice, 15(3), 141-146.
doi:10.3109/13814780903329528.</span></p>
<p class=MsoNormal><span style='font-size:9.0pt'>European Society of Cardiology
Clinical Practice Guidelines (2013). Management of Stable Coronary Artery
Disease. &nbsp;Eur Heart J 2013;34:2949–3003 - doi:10.1093/eurheartj/eht296</span></p>
<p class=MsoNormal><span style='font-size:9.0pt'>European Society of Cardiology
Clinical Practice Guidelines (2015). Management of Acute Coronary Syndromes
(ACS) in patients presenting without persistent ST-segment elevation.  European
Heart Journal, doi/10.1093/eurheartj/ehv320.</span></p>
<p class=MsoNormal><span style='font-size:9.0pt'>European Society of Cardiology
Clinical Practice Guidelines (2017). Management of Acute Myocardial Infarction
in patients presenting with ST-segment elevation. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Myocardial-Infarction-in-patients-presenting-with-ST-segment-elevation-Ma.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt'>Launbjerg J,
Fruergaard P, Hesse B, et al. Long-term risk of death, cardiac events and
recurrent chest pain in patients with acute chest pain of different origin.
Cardiology 1996; 87:60.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;background:white'>National
Institute for Health and Care Excellence (2016<i>)&nbsp;</i><em><span
style='font-family:"Arial","sans-serif";font-style:normal'>Chest pain of recent
onset: assessment and diagnosis</span></em><em><span style='font-family:"Arial","sans-serif"'>
</span></em>(NICE Guideline CG95). Available at:</span><span lang=EN-US
style='font-size:9.0pt'> https://www.nice.org.uk/guidance/cg95/evidence</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt'>McCaig, L, Burt, C.
National Hospital Ambulatory Medical <span style='color:black'>Care Survey:
2003 Emergency Department Summary. In: Advance Data from Vital and Health
Statistics. Centers for disease control and prevention, Atlanta, GA 2005.</span></span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;color:black'>Thygesen
K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial
Infarction (2018). J Am Coll Cardiol 2018; 72:2231.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;color:black'>Panju
AA, Hemmelgarn BR, Guyatt GH, Simel DL. The rational clinical examination. Is
this patient having a myocardial infarction? JAMA 1998; 280:1256.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;color:black'>Poon S,
Goodman SG, Yan RT, et al. Bridging the gender gap: Insights from a
contemporary analysis of sex-related differences in the treatment and outcomes
of patients with acute coronary syndromes. Am Heart J 2012; 163:66.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;color:black'>Pope
JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac
ischemia in the emergency department. N Engl J Med 2000; 342:1163.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;color:black'>Varwani,
M., Jeilan, M., Ngunga, M., Barasa, A. (2018). Outcomes in patients with acute
coronary syndrome in a referral hospital in sub-Saharan Africa. Cardiovascular
journal of Africa, 29, 1-5. doi: 10.5830/CVJA-2018-066.</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Ben Dowsing</span></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 03 December 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td  valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Orighomisan Agboghoroma</span></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 31 December 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td  valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td  valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td  valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added </span></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td  valign=bottom style=‘ ;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td  valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style=‘ ;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->
<div data-role="panel" data-position="right" data-display="overlay" data-position-fixed="true" data-theme="b" id="leftpanel1">
	<a href="#" data-rel="close" data-theme="b" class="ui-btn ui-corner-all ui-shadow ui-btn-a ui-icon-delete ui-btn-icon-notext ui-btn-right">Close</a>
  <h1>About this app</h1>
  <div>
    This app is designed to provide doctors and nurses with quick access to the clinical guidelines of the Clinical Services Department of the MRC Unit The Gambia at LSHTM. <br>Users will be notified of updates via departmental email. <br>For feedback or support, email fakemokwe@mrc.gm
  </div>
</div>
</div>
<div data-role="footer" data-tap-toggle="false" data-id="persistent-footer" data-position="fixed" data-theme="a">
  <a href="index.html" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-left ui-btn-icon-left ui-icon-home">Home</a>
  <a href="#" onclick="topFunction()" id="myBtn" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-right ui-btn-icon-right ui-icon-carat-u">Top</a>  
</div>
</body>
</html>
